Drug safety issues in 2002

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1370, 2003-01, pp. : 17-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug safety issues in 2001

By  

Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. : 3-6

Adis International

Access to resources Recommend Favorite

Postmarketing Drug Safety Surveillance: An Overview of Regulatory Issues

By Wu J.H.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 4, 2003-01 ,pp. : 231-244

Adis International

Access to resources Recommend Favorite

Nanotechnology in Drug Delivery: Safety and Toxicity Issues

By  

Current Pharmaceutical Design, Vol. 21, Iss. 29, 2015-10 ,pp. : 4252-4261

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory Issues of Propensity Score Methodology Application to Drug and Device Safety Studies

By Levenson Mark S.   Yue Lilly Q.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 110-121

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Problem-Oriented Approach to Safety Issues in Drug Development and Beyond

By Haas J.F.  

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 555-567

Adis International

Access to resources Recommend Favorite